J Expo Sci Environ Epidemiol by Rodr\uedguez-Carmona, Yanelli et al.
Determinants and characterization of exposure to phthalates, 
DEHTP and DINCH among pregnant women in the PROTECT 
birth cohort in Puerto Rico
Yanelli Rodríguez-Carmona, MSc1, Pahriya Ashrap, MSc1, Antonia M. Calafat, PhD2, 
Xiaoyun Ye, MD, PhD2, Zaira Rosario, MSc3, Leah D. Bedrosian, MPH1, Gredia Huerta-
Montanez, MD4, Carmen M. Vélez-Vega, PhD5, Akram Alshawabkeh, PhD6, José F Cordero, 
MD, MPH3, John D. Meeker, ScD1, Deborah Watkins, PhD1,*
1University of Michigan School of Public Health, Department of Environmental Health Sciences, 
Ann Arbor, Michigan, United States
2Centers for Disease and Control and Prevention, Atlanta, Georgia, United States
3Department of Epidemiology and Biostatistics, University of Georgia, Athens, Georgia, United 
States
4Northeastern University, Boston, Massachusetts, United States
5University of Puerto Rico Graduate School of Public Health, UPR Medical Sciences Campus, 
San Juan, Puerto Rico
6College of Engineering, Northeastern University, Boston, Massachusetts, United States
Abstract
Background: As a result of evidence suggesting phthalate toxicity, their use has decreased in 
recent years. However, new phthalates and non-phthalate replacements have emerged in their 
place, with unknown potential impacts on health.
Methods: We measured 15 phthalate, two di(2-ethylhexyl)terephthalate (DEHTP), and two 
di(isononyl)cyclohexane-1,2-dicarboxylate (DINCH) urinary metabolites, collected up to three 
times during pregnancy from 994 women in Northern Puerto Rico (2011-2017). We used tests of 
linear trend to asses changes in concentrations over time and linear mixed models to identify 
predictors of exposure (sociodemographic characteristics, drinking water sources, diet, product 
use).
Results: Several phthalate metabolites decreased over the study period indicating decreased 
exposure, while the geometric mean of DEHTP metabolites (molecular sum) increased 3-fold 
between 2014-2017. Intraclass correlations revealed low to moderate reproducibility of these 
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biomarkers across pregnancy. Several metabolites were associated with maternal age, income, 
education, pre-pregnancy BMI, drinking public water, use of cleaning and personal care products 
and ice cream consumption. DINCH metabolite concentrations remained low throughout the study 
period.
Conclusion: Although exposure to some phthalates may be decreasing, exposure to 
replacements, such as DEHTP, is increasing. Additional studies are needed to further characterize 
sources of phthalate replacement chemicals and potential exposure-related health effects among 
vulnerable populations.
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Introduction
Phthalates are chemicals widely used in industrial and consumer applications, resulting in 
ubiquitous human exposure (1). High molecular weight phthalates such as di(2-ethylhexyl) 
phthalate (DEHP), di-isononyl phthalate (DINP) and dioctyl phthalate, are used as 
plasticizers in polyvinyl chloride (PVC) plastics, food packaging, medical devices and vinyl 
products, while low molecular weight phthalates such as diethyl phthalate (DEP) and dibutyl 
phthalate (DBP) are used as solvents in personal care products including perfumes, lotions 
and cosmetics (2). Epidemiological studies suggest that phthalate exposure during pregnancy 
is associated with increased risk of pregnancy loss, preeclampsia, preterm birth and 
gestational hypertension (3-9). In addition, gestational phthalate exposure has been 
associated with altered neurodevelopment (10-13), endocrine, reproductive (14-18), and 
cardiometabolic outcomes during infancy and childhood (19-22).
In response to concerns about the safety of exposure, several phthalates have been banned 
from use in children’s toys and other child care articles in the United States. However, 
phthalate alternatives, including di-2-ethylhexyl terephthalate (DEHTP) and 
di(isononyl)cyclohexane-1,2-dicarboxylate (DINCH), are now being used in their place for a 
variety of consumer applications with limited information on potential impacts on health 
(23, 24). DEHTP is now used in flexible PVC products, children’s toys, medical devices and 
food contact materials in place of DEHP (23). Current studies in human exposure provide 
evidence for this trend, as several studies demonstrate decreases in urinary DEHP metabolite 
concentrations in recent years (25-28), while urinary DEHTP metabolites have increased 
(25, 29). Similarly, DINCH is now used in the U.S. in a range of applications, including 
children’s toys, food contact materials, vinyl flooring and medical devices (30). With 
increasing demand and use of phthalate replacement chemicals, studies show increasing 
detection of urinary DINCH metabolites both within the U.S. (24) and elsewhere (31-33). 
Although epidemiological studies of health effects related to DEHTP or DINCH exposure 
are extremely limited (34), recent animal studies suggest that gestational DINCH exposure 
can affect the function of Leydig cells, which produce testosterone and other androgens (35). 
In addition, DINCH metabolites can activate human estrogen receptor (ER) α, ERβ, 
androgen receptor, peroxisome proliferator-activated receptor (PPAR) α and PPARγ (36), 
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which play key roles in metabolism, inflammation, and many other disease processes (37, 
38).
In a study of DEHTP exposure in rats, adverse effects on reproductive system, kidneys or 
liver were not observed (39), however the chronic oral intake of DEHTP in animal models 
have reported general toxicity related to changes in hematologic parameters and weight loss 
(40). Additionally, in a study of DEHP and DEHP replacements utilizing a murine cell line, 
DEHP was more cytotoxic that DINCH, but the decrease in cell viability was ≤50% for both 
compounds. Interestingly, mono-(2-ethylhexyl) phthalate (MEHP, a DEHP metabolite) and 
several DINCH and DEHTP metabolites presented more cytotoxic dose-response effects 
than their parent compounds at the same concentrations, with MEHP having the smallest 
effect of all metabolites (41). These findings highlight the need for characterizing and 
identifying sources of exposure to both phthalates and phthalate replacement chemicals, 
particularly among pregnant women and children.
In the present study, we measured urinary concentrations of metabolites of phthalates, 
DEHTP, and DINCH among women from the Puerto Rico Testsite for Exploring 
Contamination Threats (PROTECT) birth cohort at three time points during pregnancy as 
biomarkers of prenatal exposure. We characterized trends in plasticizer exposure over time 
and evaluated self-reported demographic, socioeconomic, product use, and diet information 
as predictors of urinary metabolite concentrations to help inform potential sources of 
exposure.
Methods
Study participants
Pregnant women were recruited from prenatal clinics and hospitals in northern Puerto Rico 
for participation in the PROTECT prospective birth cohort in 2010 through 2017. Women 
were recruited at approximately 14 ± 2 weeks of gestation (n=994) and were eligible if they 
were between 18 to 40 years old, lived in the Northern karst region, did not use oral 
contraceptives three months prior to pregnancy, did not use in vitro fertilization to become 
pregnant, and did not have known medical/obstetrics complications. The sample size 
required for this ongoing birth cohort was determined based on investigating relationships 
between environmental exposures with preterm birth, however, previous analyses have 
demonstrated that this sample size is more than adequate to assess predictors of exposure. 
Prenatal spot urine samples were collected at study visits at approximately 18, 22 and 26 
weeks of gestation, and information on demographic and socioeconomic factors, as well as 
self-reported product use and food consumption in the previous 48 hours was collected using 
questionnaires at each study visit. Research protocols were reviewed and approved by the 
Ethics and Research Committees of the University of Puerto Rico, the University of 
Michigan School of Public Health, Northeastern University, and participating hospitals and 
clinics. All study participants provided informed consent prior to participation. Involvement 
of the CDC was determined not to constitute engagement in human subjects research.
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Urinary Biomarker Measurements
Urine was collected in polypropylene containers, divided into aliquots, and frozen at −80 °C 
until shipment overnight to the Division of Laboratory Sciences at the Centers for Disease 
Control and Prevention (CDC) for analysis. CDC personnel were blinded to all participant 
information. Urinary concentrations of 15 phthalate, two DEHTP, and two DINCH 
metabolites were measured using on-line solid phase extraction coupled with isotope 
dilution-high performance liquid chromatography-electrospray ionization-tandem mass 
spectrometry as previously described (24, 29, 42). Measured phthalate metabolites 
comprised mono(2-ethylhexyl) phthalate (MEHP), mono(2-ethyl-5-hydroxyhexyl) phthalate 
(MEHHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), mono(2-ethyl-5-carboxypentyl) 
phthalate (MECPP), mono-benzyl phthalate (MBzP), monocarboxyoctyl phthalate (MCOP), 
mono-isononyl phthalate (MNP), mono-oxoisononyl phthalate (MONP), monocarboxynonyl 
phthalate (MCNP), mono (3-carboxypropyl) phthalate (MCPP), mono-ethyl phthalate 
(MEP), mono-n-butyl phthalate (MBP), mono-3-hydroxybutyl phthalate (MHBP), mono-
isobutyl phthalate (MiBP) and mono-2-hydroxy-iso-butyl phthalate (MHiBP). Measured 
DEHTP metabolites comprised mono-2-ethyl-5-carboxypentyl terephthalate (MECPTP) and 
mono-2-ethyl-5-hydroxyhexyl terephthalate (MEHHTP) (23, 43). Measured DINCH 
metabolites were cyclohexane-1,2-dicarboxylic acid monohydroxy isononyl ester 
(MHiNCH) and cyclohexane-1,2-dicarboxylic acid monocarboxy isooctyl ester (MCOCH) 
(24). The sum of di-2-ethylhexyl phthalate metabolites (ΣDEHP) was calculated by adding 
the molar fractions of MEHP, MEHHP, MEOHP and MECPP; the sum of dibutyl phthalate 
(ΣDBP) was calculated by adding the molar fractions of MBP and MHBP; the sum of di-
isobutyl phthalate (ΣDiBP) by adding the molar fractions of MiBP and MHiBP; and di(2-
ethylhexyl)terephthalate (ΣDEHTP) by adding the molar fractions of MECPTP and 
MEHHTP. To achieve unit comparability, ΣDEHP (nmol/ml) was multiplied by the 
molecular weight (MW) of MEHP (278.348 g/mol), ΣDBP (nmol/ml) by the MW of MnBP 
(222.24 g/mol), ΣDiBP (nmol/ml) by the MW of MiBP (222.24 g/mol) and ΣDEHTP 
(nmol/ml) by the MW of MEHHTP (294.34 g/mol). The resulting units were ng/ml. The 
number of samples analyzed for each metabolite are presented in Supplemental Material 
Table S1, stratified separately by prenatal visit and by year of sample collection. Specific 
gravity (SG) was measured using a handheld digital refractometer (Atago Co., Ltd., Tokyo, 
Japan) at the University of Puerto Rico Medical Sciences Campus at the time of sample 
collection. Values below the limit of detection (LOD) were imputed with the metabolite-
specific LOD/√2 (44).
Statistical Analysis
First, geometric means, geometric standard deviations, and percentiles were calculated to 
describe distributions of urinary biomarker concentrations. We compared geometric means 
of urinary biomarker concentrations among PROTECT women to concentrations reported in 
NHANES 2011-2016 (45) among women aged 16 to 49 years using a two-sample t-test. For 
the following analyses, biomarker concentrations were natural log-transformed for 
normalization, and corrected for SG to account for urinary dilution. The SG correction was 
made according to the following formula (46): Pc=P (1.019-1)/(SG-1); where Pc = corrected 
metabolite concentration, P = measured metabolite concentration, SG = SG of the sample, 
and 1.019 = median SG of all samples collected. Spearman rank correlations were calculated 
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to assess relationships between phthalate and phthalate replacement metabolites. Differences 
in biomarker concentrations by study visit were tested using linear mixed models to account 
for within participant correlation, and intraclass correlation coefficients (ICCs) were 
calculated to assess the reproducibility and variability of biomarker concentrations across 
pregnancy. Changes in biomarker concentrations by year were also assessed to determine 
trends in individual metabolites over time using tests of linear trend. Population geometric 
mean concentrations of SG-corrected biomarker concentrations were calculated across 
demographic and socioeconomic factors, such as maternal age, education, employment, 
marital status, and income, as well as pre-pregnancy body mass index (BMI). We used linear 
mixed effects models with compound symmetry covariance structure (47) to examine 
relationships of urinary biomarker concentrations with demographic and socioeconomic 
factors, reported water use, water sources and storage, and 48-hour recall of product use and 
food consumption. Linear mixed models include both fixed and random effects to account 
for intra-individual correlation between repeated measures. For metabolites detected in less 
than 80% of samples, generalized linear mixed effects models with the logistic link function 
were used to determine predictors of metabolite detection versus non-detection. In response 
to potential time trends in phthalate use in manufacturing, we assessed changes in 
associations between personal care product use and biomarker concentrations over time by 
evaluating interactions between predictors and year of sample collection. Our analyses met 
the appropriate statistical assumptions and were conducted using R version 3.2.2 and SAS 
9.4 (SAS Institute Inc., Cary, NC), with code available upon request.
Results
The mean age of study participants was 26.8 years, 92% had a high school education or 
higher, and the majority of women reported a household income below $40 000 per year. 
Less than 1% of participants reported ever smoking cigarettes, 56% were underweight (BMI 
≤25 kg/m2), on average they had one child previous to study participation, and 78% were 
either married or living with their partner (48).
Distributions and time trends
With the exception of MNP, MHiNCH, and MCOCH, all phthalate and DEHTP metabolites 
were detected in at least 82% of the 2027 urine samples analyzed, representing widespread 
prenatal exposure among 994 PROTECT participants (Table 1). MNP and the DINCH 
metabolites MCOCH and MHiNCH were detected in 29, 18 and 35 percent of PROTECT 
samples, respectively. However, detection rates of DINCH metabolites increased over time, 
with MHiNCH detected in 26% of samples in 2013-2014 and 45% of samples in 2015-2017. 
A similar trend was seen for MCOCH, with detection rates increasing from 8% to 24% in 
the same time frame, although geometric mean concentrations of both metabolites remained 
just above the LOD (Supplemental Material Table S1). In comparison to female NHANES 
participants of child-bearing age, PROTECT women had significantly higher concentrations 
of MEHP, MEOHP, MECPP, MBP, MHBP, MiBP, MHiBP, and MECPTP, but significantly 
lower concentrations of MBzP, MCOP, MONP, MCNP, MCPP, and MEHHTP (Table 1).
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Within the PROTECT samples, metabolites from the same parent compound tended to be 
highly correlated with one another, including the DEHP metabolites (MEHP, MEHHP, 
MEOHP, and MECPP; r >0.7), DBP metabolites (MBP, MHBP; r=0.88), di-isobutyl 
phthalate (DiBP) metabolites (MiBP, MHiBP; r=0.67), and DEHTP metabolites (r=0.84).
Geometric mean concentrations of MBzP and ΣDBP metabolites differed significantly 
across the three prenatal study visits, with higher concentrations at the first and second visits 
compared to the third (Supplemental Material Figure S1). ICCs for SG-corrected metabolite 
concentrations ranged from 0.16 to 0.57 (Supplemental Material, Table S2). MEP, MBzP 
and ΣDiBP metabolites had the highest reproducibility across pregnancy with ICCs of 0.46, 
0.49, and 0.56, respectively, while MCNP and MONP had the lowest ICCs (0.16 and 0.18).
With the exception of MONP, geometric mean concentrations of all phthalate metabolites 
significantly decreased over the study period of 2011 to 2017, while concentrations of 
DEHTP metabolites increased (Figure 1 and Supplemental Material Table S1). For example, 
ΣDEHP concentrations decreased by almost 50%, from 43 ng/ml in 2011 to 23 ng/ml in 
2017. In contrast, although DEHTP metabolites were only measured from 2014 onward, 
they increased 192% during this time frame.
Predictors of urinary phthalate and phthalate replacement metabolite concentrations
Higher maternal age and education were both associated with higher MCOP, MCNP, and 
ΣDEHTP metabolites and lower concentrations of MBzP, ΣDEHP and ΣDBP (Table 2). For 
example, women who were over 30 years of age had on average 10% lower ΣDEHP and 
63% higher ΣDEHTP metabolite concentrations compared to women who were less than 25 
years of age. Higher education level was also associated with higher odds of detectable MNP 
concentrations when compared to women with the lowest level of education (Table S3). 
Similarly, higher income was associated with higher MCOP, MCNP and ΣDEHTP, but lower 
MBzP and ΣDBP concentrations, with similar patterns observed with employment status 
(Table 2). Single women had significantly higher MBzP, and MEP, while women who were 
married or in a domestic partnership had significantly higher MCOP and MCNP. With the 
exception of the ΣDEHTP metabolites, all phthalate metabolites were significantly higher 
among women who were obese (BMI ;30 kg/m2) prior to pregnancy (Table 2). Obese 
women also had higher odds of detectable levels of both DINCH metabolites (MCOCH and 
MHiNCH) (Table S3).
The use of perfume, cosmetics and “other hair products” within the 48 hours prior to urine 
sample collection was associated with 33.8, 12.2 and 22.6 ng/mL higher MEP 
concentrations, respectively, while hairspray use was negatively associated with MCOP 
(Table 3). In addition, shampoo and conditioner use was associated with higher odds of 
detectable MCOCH, while shaving cream use was associated with lower odds of detectable 
MNP (Table S4). There was a general trend of reported use of detergents, cleaners, or liquid 
soap associated with lower phthalate metabolite concentrations (Table 3). For example, 
liquid soap use was associated with lower MCOP and MCPP (Table 3). With the exception 
of ΣDBP and use of bar soap, there were no significant interactions between personal care 
product use and year of sample collection. In stratified analyses, the use of bar soap was 
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marginally associated with higher ΣDBP concentrations in 2011-2013 (p=0.06), but not in 
later years (2014-2017).
Eating ice cream in the 48 hours prior to sample collection was the only food item 
associated with higher phthalate metabolite concentrations, specifically MCOP, MCNP, and 
MCPP. In contrast, women who reported eating chicken or cheese in the previous 48 hours 
had lower MBzP concentrations compared to women who did not eat these foods, and eating 
meat was associated with lower concentrations of MONP (Table 4). Additionally, recently 
drinking milk was associated with decreased odds of detectable MHiNCH (Table S5).
Women who reported their primary drinking water source as public water supplied by the 
Autoridad de Acueductos y Alcantarillados de Puerto Rico (AAA) had higher concentrations 
of MBzP (23%), MCPP (11%), ΣDBP (19%) and ΣDiBP (14%) compared to women who 
reported drinking primarily bottled water (Table 4). Conversely, the primary use of bottled 
water for cooking and drinking was associated with higher odds of detectable MCOCH and 
MHiNCH (DINCH metabolites) when compared to AAA water (Table S5). In addition, 
storing water in a cistern made of plastic, metal, or other materials was associated with 
higher MONP concentrations and decreased MHiNCH detection. Finally, among women 
who reported drinking primarily AAA water, those who filtered their drinking water at home 
had lower MBzP and ΣDBP, but higher MCOP and MCNP concentrations (Table 4).
Discussion
In the present study, we characterize biomarkers of exposure to several phthalates and 
phthalate replacements among pregnant women participating in the PROTECT birth cohort 
study. This analysis builds on preliminary work (49) by providing new information on trends 
in phthalate exposure over time in this cohort, new data on exposure to phthalate 
replacements such as DEHTP and DINCH, and examining predictors of exposure 
biomarkers in a much larger sample size, including urinary phthalate and phthalate 
replacement metabolite measurements from repeated samples collected from 994 pregnant 
PROTECT participants from 2011 to 2017.
We observed a decreasing trend of almost all urinary phthalate metabolite concentrations, 
with the exception of MONP, over the course of 7 years in the PROTECT population. The 
reduction in DEHP, DBP, DEP and benzyl butyl phthalate (BBzP) exposure in the last 16 
years has been reported previously in the U.S. general population. This trend might be 
derived from health concerns regarding these chemicals and subsequent changes in 
legislation and consumer practices (50), leading to the increasing use of phthalate 
replacements. Indeed, metabolites of DEHTP – a DEHP structural isomer and phthalate 
replacement – increased between 2014 and 2017 among PROTECT women. This is 
consistent with previous reports utilizing spot urine samples from U.S. adults collected from 
2000 to 2016, in which an increasing percentage of detection and concentrations were 
observed for MEHHTP (range: 7 to 91%; <LOD to 3.1 ng/ml_) and MECPTP (range: 18–
100%; <LOD to 13.1 ng/ml), while the DEHP metabolites, MEHHP and MECPP decreased 
53% and 44.6%, respectively, in the 16 year period (25). Additionally, NHANES results 
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from 2015-2016 confirm that DEHTP exposure is now widespread within the U.S. 
population (29).
The observed differences in the biomarker concentrations of the PROTECT women (2010- 
2017) when compared to the NHANES 2011-2016, could be attributed in part to the time 
period evaluated and the fact that the NHANES sample included non-pregnant women, who 
may possibly have different exposure sources and consumer habits than pregnant women in 
Puerto Rico. The measured urinary phthalate and phthalate replacement metabolites had low 
to moderate reproducibility during pregnancy. Compared to two cohorts of pregnant women 
in the mainland U.S. (51, 52), the reproducibility of MiBP among PROTECT women was 
similar, while the reproducibility of DEHP metabolites, MBzP, MCPP, MEP and MBP 
showed more variability across studies. These variances could be attributed to differences in 
consumer habits and product usage related to product access or cultural habits, as well as 
timing (53) or frequency of the measurements.
We observed associations between higher MBzP and ΣDBP concentrations with 
demographic and socioeconomic characteristics such as being single, unemployed, and with 
lower age, education, and income. On the other hand, we observed that being married, 
employed, or higher age, education and income was associated with higher MCOP, MCNP 
and ΣDEHTP metabolite concentrations. Associations between markers of phthalate 
exposures and socioeconomic factors have been reported previously among pregnant women 
(54-56). Together, these findings suggest different sources of phthalate and phthalate 
replacement exposure according to demographic and socioeconomic characteristics, and 
potential differences in phthalate usage in various consumer products. For example, diet (49, 
57-59), household products, and personal care products are important known sources of 
phthalate exposures (60). However, while diet is influenced by diverse factors, such as race, 
socioeconomic status and education (61-63), the factors that affect the access or decision to 
buy certain consumer products are unclear. For instance, the higher price of phthalate-free 
alternatives (64) and the awareness of the effects of chemical exposures might play a role in 
purchasing decisions. Women with higher education might consider environmental 
exposures as “dangerous” and consequently try to consume organic food, avoid fast food, 
and buy eco-friendly products (65), whereas women with lower income may not be able to 
do so. For these reasons, it is possible that the observed differences in phthalate and 
phthalate replacement exposures by socioeconomic variables might be explained by the 
amount and quality of purchased dietary and personal care products.
Urinary concentrations of MBzP and MONP, as well as detection of MNP and DINCH 
metabolites, were negatively associated with the consumption of dairy and meat products. 
This is somewhat consistent with findings from The Infant Development and Environment 
Study (TIDES) in which the frequency of consumption of dairy products was negatively 
associated in a dose-response manner to MiBP and ΣDEHP urine concentrations (57). 
However, in the present study, ice cream consumption was associated with increased 
concentrations of several phthalate metabolites (MCOP, MCNP and MCPP). This may 
possibly be due to the high fat content of ice cream, as previous studies suggest that fatty 
foods may increase migration of phthalates from plastic food packaging into food products 
(66).
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Phthalate exposure through the use of personal care products has been reported extensively 
in the literature (60, 67-69), and our findings in the present study are generally consistent 
with previous reports. For example, perfume, cosmetics, and hair product use were all 
positively associated with urinary MEP. Personal care product use was not associated with 
ΣDEHTP and its metabolites and inconsistently associated with detection of DINCH 
metabolites, which is somewhat expected, as these phthalate replacements may be typically 
used for other applications (e.g. plastics) (70). We also observed negative associations 
between cleaning products, such as liquid soap or detergent, and a number of phthalate 
metabolites. This may be consistent with previous research in which hand-washing was 
associated with a 35-75% reduction of phthalates on hands (71), suggesting a reduction in 
exposure by the removal of phthalates from the skin.
Interestingly, urinary phthalate concentrations (MBzP, MCPP, ΣDBP, and ΣDiBP), and 
detection of DINCH metabolites were higher among women whose primary drinking water 
source was public water compared to bottled water. These findings are in the context of 
extensive contamination of water resources in Northern Puerto Rico (72, 73) by phthalates 
derived from rainwater runoff and industrial (mining, pharmaceutical) and domestic 
activities (74). Moreover, wastewater treatment plants do not remove 100% of phthalates 
from discharged water, which may further contaminate additional water sources (75). 
Additionally, DEHTP could leach from polyethylene terephthalate water bottles, which 
could potentially explain higher, although not statistically significant, ΣDEHTP metabolite 
concentrations among women who reported using bottled water for drinking and cooking 
compared to women using public water.
The relation between patterns of consumer product use and environmental exposures is 
complex and influenced by several factors, such as the time period, socioeconomic 
characteristics, location, housing, diet and physiology (76), some of which may also differ 
between Puerto Rico and the mainland U.S. This makes it complicated to fully characterize 
sources of phthalate and phthalate replacement exposure, especially considering the diversity 
of consumer products on the market (77), regional differences in products available in Puerto 
Rico and mainland U.S., temporal changes in product composition, and the frequent 
appearance of new replacement chemicals (78). One limitation of the present study is the 
lack of information on potentially important sources of phthalate and phthalate replacement 
exposure, such as medical devices, other housing products and characteristics, childcare 
products, toys, and textiles (78). Due to the relatively low detection frequency of MNP and 
DINCH metabolites, we also were not able to assess associations between urinary 
concentrations and product use or evaluate temporal changes of these chemicals during 
pregnancy and during the study period. In addition, we were unable to assess metabolite 
concentrations in relation to use of fragrance-free products due to a very small number of 
women who reported using these products. Finally, due to the multiple comparisons 
evaluated in this analysis, the role of chance in our findings should not be ruled out. Despite 
these limitations, one strength of the study is repeated measurements of phthalate and 
phthalate replacement metabolites across three separate visits in pregnancy. Phthalates are 
quickly metabolized and excreted, thus have short biological half-lives (hours), so repeated 
measurements allow us to more accurately characterize exposure during pregnancy. In 
addition, urinary phthalate levels reflect only recent exposure, so concurrent collection of 
Rodríguez-Carmona et al. Page 9
J Expo Sci Environ Epidemiol. Author manuscript; available in PMC 2020 March 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
product use information in the 48 hours prior to sample collection is a strength that allowed 
us to identify several predictors of urinary phthalate and phthalate replacement metabolite 
levels. Additionally, we were able to assess important temporal trends in exposure biomarker 
levels across 7 years among PROTECT women.
Conclusion
The current study characterized temporal changes in and predictors of urinary phthalate and 
phthalate replacement metabolites among pregnant women in Puerto Rico in the context of 
changing trends in the global use of phthalates and their replacements. Our results suggest 
the increasing replacement of traditionally used phthalates for alternative plasticizers, such 
as DEHTP. Future epidemiological studies should evaluate sources of, and health effects 
related to exposure to phthalate replacements, such as DINCH and DEHTP, as these 
exposures may be increasing, with unknown effects on health.
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Figure 1. 
Comparison of SG-corrected urinary phthalate and phthalate replacement metabolite 
concentrations by year (2011-2017).
Note: Temporal trends for all metabolites were statistically significant (p<0.05), with the 
exception of MONP. The y-axis is presented on the logarithmic scale.
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